163 related articles for article (PubMed ID: 22307062)
1. Quality of life and survival in advanced cervical cancer: a Gynecologic Oncology Group study.
Chase DM; Huang HQ; Wenzel L; Cella D; McQuellon R; Long HJ; Moore DH; Monk BJ
Gynecol Oncol; 2012 May; 125(2):315-9. PubMed ID: 22307062
[TBL] [Abstract][Full Text] [Related]
2. Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
Reck M; Thatcher N; Smit EF; Lorigan P; Szutowicz-Zielinska E; Liepa AM; Winfree KB; Peterson P; Guba SC; Socinski MA
Lung Cancer; 2012 Dec; 78(3):276-81. PubMed ID: 23043970
[TBL] [Abstract][Full Text] [Related]
3. Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study.
Monk BJ; Huang HQ; Cella D; Long HJ;
J Clin Oncol; 2005 Jul; 23(21):4617-25. PubMed ID: 15911864
[TBL] [Abstract][Full Text] [Related]
4. Surviving cervical cancer: does health-related quality of life influence survival?
Ashing-Giwa KT; Lim JW; Tang J
Gynecol Oncol; 2010 Jul; 118(1):35-42. PubMed ID: 20382414
[TBL] [Abstract][Full Text] [Related]
5. Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study.
McQuellon RP; Thaler HT; Cella D; Moore DH
Gynecol Oncol; 2006 May; 101(2):296-304. PubMed ID: 16376417
[TBL] [Abstract][Full Text] [Related]
6. Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from Eastern Cooperative Oncology Group Study 5592.
Eton DT; Fairclough DL; Cella D; Yount SE; Bonomi P; Johnson DH;
J Clin Oncol; 2003 Apr; 21(8):1536-43. PubMed ID: 12697878
[TBL] [Abstract][Full Text] [Related]
7. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.
Carey MS; Bacon M; Tu D; Butler L; Bezjak A; Stuart GC
Gynecol Oncol; 2008 Jan; 108(1):100-5. PubMed ID: 17920108
[TBL] [Abstract][Full Text] [Related]
8. Life after total laryngectomy: a measure of long-term survival, function, and quality of life.
Woodard TD; Oplatek A; Petruzzelli GJ
Arch Otolaryngol Head Neck Surg; 2007 Jun; 133(6):526-32. PubMed ID: 17576901
[TBL] [Abstract][Full Text] [Related]
9. Single- vs. multiple-item instruments in the assessment of quality of life in patients with advanced cancer.
Bush SH; Parsons HA; Palmer JL; Li Z; Chacko R; Bruera E
J Pain Symptom Manage; 2010 Mar; 39(3):564-71. PubMed ID: 20303030
[TBL] [Abstract][Full Text] [Related]
10. Healthy-related quality of life in patients with cervical cancer in Southwest China: a cross-sectional study.
Zhao M; Luo L; Zhang CH; Zhang JP; Yuan JY; Gu RY; Ding SR
BMC Health Serv Res; 2021 Aug; 21(1):841. PubMed ID: 34412641
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.
Rose PG; Ali S; Watkins E; Thigpen JT; Deppe G; Clarke-Pearson DL; Insalaco S;
J Clin Oncol; 2007 Jul; 25(19):2804-10. PubMed ID: 17502627
[TBL] [Abstract][Full Text] [Related]
12. Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study.
Long HJ; Monk BJ; Huang HQ; Grendys EC; McMeekin DS; Sorosky J; Miller DS; Eaton LA; Fiorica JV;
Gynecol Oncol; 2006 Mar; 100(3):537-43. PubMed ID: 16216315
[TBL] [Abstract][Full Text] [Related]
13. Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study.
Rose PG; Ali S; Whitney CW; Lanciano R; Stehman FB
Gynecol Oncol; 2011 Jun; 121(3):542-5. PubMed ID: 21420157
[TBL] [Abstract][Full Text] [Related]
14. The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a Gynecologic Oncology Group Study.
von Gruenigen VE; Huang HQ; Gil KM; Frasure HE; Armstrong DK; Wenzel LB
Gynecol Oncol; 2012 Mar; 124(3):379-82. PubMed ID: 22119995
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for recurrent cervical cancer.
Pectasides D; Kamposioras K; Papaxoinis G; Pectasides E
Cancer Treat Rev; 2008 Nov; 34(7):603-13. PubMed ID: 18657909
[TBL] [Abstract][Full Text] [Related]
16. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.
Long HJ; Bundy BN; Grendys EC; Benda JA; McMeekin DS; Sorosky J; Miller DS; Eaton LA; Fiorica JV;
J Clin Oncol; 2005 Jul; 23(21):4626-33. PubMed ID: 15911865
[TBL] [Abstract][Full Text] [Related]
17. Correlation of angiogenesis and recurrence-free survival of early stage cervical cancer patients undergoing radical hysterectomy with pelvic lymph node dissection.
Phoophitphong T; Hanprasertpong J; Dechsukhum C; Geater A
J Obstet Gynaecol Res; 2007 Dec; 33(6):840-8. PubMed ID: 18001452
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.
Lim A; Sia S
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1431-8. PubMed ID: 21640504
[TBL] [Abstract][Full Text] [Related]
19. Causal relationship between health promoting behavior and quality of life in cervical cancer patients undergoing radiotherapy.
Taechaboonsermsak P; Kaewkungwal J; Singhasivanon P; Fungladda W; Wilailak S
Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1568-75. PubMed ID: 16610663
[TBL] [Abstract][Full Text] [Related]
20. Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: a Gynecologic Oncology Group study.
Waggoner SE; Darcy KM; Fuhrman B; Parham G; Lucci J; Monk BJ; Moore DH;
Gynecol Oncol; 2006 Dec; 103(3):853-8. PubMed ID: 16815535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]